Niels Halama

18PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersCellular immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 05, 2025
Interdisciplinary evidence-based tumor board simulation training in surgical medical education.

Nora Corinna Altmayer, Elias Khajeh, Johanna Fellhofer-Hofer

|Jul 14, 2025
Diabetes and Colorectal Cancer Risk and Survival According to Tumor Immunity Status.

Durgesh Wankhede, Niels Halama, Matthias Kloor

|Apr 28, 2025
Prognostic Value of CD8+ T Cells at the Invasive Margin Is Comparable to the Immune Score in Nonmetastatic Colorectal Cancer: A Prospective Multicentric Cohort Study.

Durgesh Wankhede, Niels Halama, Matthias Kloor

|Jul 15, 2022
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Thomas Walle, Sunanjay Bajaj, Joscha A Kraske

|Jun 17, 2022
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Thomas Walle, Sunanjay Bajaj, Joscha A Kraske

|Feb 07, 2022
Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma.

Azaz Ahmed, Sophia Köhler, Rosa Klotz

Pageof 3

Frequent Collaborators

3 joint publications

Michael Hoffmeister

2 joint publications

Jakob Nikolas Kather

2 joint publications

Joscha A Kraske

2 joint publications

Meggy Suarez-Carmona